Moderate riskFDA DrugClass III

ImprimisRx ophthalmic solution recalled for subpotent drug formulation

ImprimisRx NJ LLC is recalling specific lots of Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution used in medical offices because the medication contains lower-than-intended active ingredients. The affected lots may not work as intended for their intended use.

From the FDA notice · Read the official notice ↗

What to do

  1. If your medical office received this product, stop using the affected lots (26JAN035 and 26FEB015) immediately
  2. Contact ImprimisRx NJ LLC or your supplier about replacement product
  3. Consult your eye care provider if you received this medication and have concerns

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-732-10
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
772 bottles
Illnesses reported
None reported
Manufactured in
1705 Us Highway 46 Ste 4, Ledgewood, NJ, United States
Classification
Class III
Recall number
D-0835-2026

In the FDA's words

Description
Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-732-10 Subpotent Drug Lot #: 26JAN035, BUD 09/07/2026; 26FEB015, BUD 09/24/2026 Distribution: USA Nationwide Affected quantity: 772 bottles
Hazard
Subpotent Drug

Related topics

PotencyDrugsSold nationwideMore from FDA Drug